<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82167">
  <stage>Registered</stage>
  <submitdate>23/07/2007</submitdate>
  <approvaldate>23/07/2007</approvaldate>
  <actrnumber>ACTRN12607000386437</actrnumber>
  <trial_identification>
    <studytitle>Effectiveness of Sensorimotor Training in patients with rheumatoid arthritis  a randomised controlled trial.</studytitle>
    <scientifictitle>A randomised controlled trial to evaluate the effectiveness of Sensorimotor Training in patients with rheumatoid arthritis</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>New secondary ID. Please modify.</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Rheumatoid Arthritis</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Rheumatoid arthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention 2 times a week for 16 weeks, 50 patients per group.
2 Groups
Intervention group
Group 1: Perturbation training: balance training (feet together, semi and tandem position, one leg stance, and unstable platforms), coordination and agility training (gait speed, shuttle walk, tandem walk, crossover walk, side-to-side walk, and carioca)
</interventions>
    <comparator>Control Group:
Group 2: the Control group does not receive any intervention.
Assessed pre and immediately post 16 weeks.</comparator>
    <control>Active</control>
    <interventioncode>Rehabilitation</interventioncode>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Health Assessment Questionary (HAQ)</outcome>
      <timepoint>Assessed pre, 12 weeks, immediately post intervention (16 weeks) and 4 weeks post intervention.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Timed up and go test</outcome>
      <timepoint>Assessed pre, 12 weeks, immediately post intervention (16 weeks) and 4 weeks post intervention.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Berg Balance Scale (BBS)</outcome>
      <timepoint>Assessed pre, 12 weeks,immediately post intervention (16 weeks) and 4 weeks post intervention.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Tinetti Test</outcome>
      <timepoint>Assessed pre, 12 weeks,immediately post intervention (16 weeks) and 4 weeks post intervention.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Short Form - 36</outcome>
      <timepoint>Assessed pre, 12 weeks,immediately post intervention (16 weeks) and 4 weeks post intervention.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Rheumatoid arthritis patients </inclusivecriteria>
    <inclusiveminage>45</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Not controlled Arterial HypertensionNot controlled Diabetes MellitusOther rheumatic diseases, with exception for osteoarthritis.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed opaque envelopes</concealment>
    <sequence>Computerised sequence generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>the people assessing the outcomes (assessor) and the people analysing the results/data (data analyst) will be blinded</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>False</masking3>
    <masking4>False</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>1/03/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>129</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>S?o Paulo - SP</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Kelson Nonato Gomes da Silva</primarysponsorname>
    <primarysponsoraddress>146, Elísio de Carvalho Street - São Paulo-SP</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Ambulatory of Specialities of Grajau</fundingname>
      <fundingaddress>Rua Artur Nascimento Junior, 120 - S?o Paulo - SP</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University Federeal of S?o Paulo - UNIFESP/EPM</fundingname>
      <fundingaddress>598, Pedro Toledo Street - S?o Paulo-SP</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Other Collaborative groups</sponsortype>
      <sponsorname>Virgínia Fernandes Moça Trevisani</sponsorname>
      <sponsoraddress>598, Pedro Toledo Street - São Paulo-SP</sponsoraddress>
      <sponsorcountry>Brazil</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>purpose of the study: verify the effectiveness of sensorimotor training in the  improvement of the quality of life and functional capacity in patients with rheumatoid arthritis.
Hypothesis:
Sensorimotor training improves the quality of life and functional capacity in patients with rheumatoid arthritis.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Federal University of São Paulo</ethicname>
      <ethicaddress />
      <ethicapprovaldate>14/11/2006</ethicapprovaldate>
      <hrec>CEP 1092/05</hrec>
      <ethicsubmitdate />
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mrs</title>
      <name>Maria Stella Peccin</name>
      <address>Rua Pedro de Toledo 598</address>
      <phone>55 - 11 - 55752970</phone>
      <fax />
      <email>stella@webtvinterativa.com</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Kelson Nonato Gomes da Silva</name>
      <address>Rua Pedro de Toledo 598</address>
      <phone>55 - 11 - 55752970</phone>
      <fax />
      <email>kelson_fisio@hotmail.com</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Kelson Nonato Gomes da Silva</name>
      <address>1666, Leôncio Ferraz, Street</address>
      <phone>+55 086 88130553</phone>
      <fax />
      <email>kelson_fisio@hotmail.com</email>
      <country>Brazil</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>